Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Neurology(R) Neuroimmunology & Neuroinflammation|August 8, 2022
Cerebellar Ataxia With Anti-DNER Antibodies: Outcomes and Immunologic FeaturesElise Peter, Le Duy Do, Salem Hannoun, et al.
Blood|November 18, 2023
The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patientsHervé Ghesquières, Daphné Krzisch, Emmanuelle Nicolas-Virelizier, et al.
Blood Advances|June 10, 2020
Gene expression profiling of gray zone lymphomaClémentine Sarkozy, Lauren Chong, Katsuyoshi Takata, et al.
EMBO Molecular Medicine|February 17, 2016
Targeting netrin-1/DCC interaction in diffuse large B-cell and mantle cell lymphomasLaura Broutier, Marion Creveaux, Jonathan Vial, et al.
Blood|November 14, 2022
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1Lorric Delage, Mireille Lambert, Émilie Bardel, et al.
Blood Advances|August 24, 2021
Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specifiedEstelle Bourbon, Delphine Maucort-Boulch, Juliette Fontaine, et al.
Cancer Medicine|May 11, 2022
Clinical presentation, outcome, and prognostic markers in patients with intravascular large B-cell lymphoma, a lymphoma study association (LYSA) retrospective studyAntoine Bonnet, Céline Bossard, Ludovic Gabellier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 24, 2025
Detection of fungal pathogens by a histomolecular approach using targeted-massive parallel sequencing on formalin-fixed tissues: a retrospective studyAlexis Trecourt, Meja Rabodonirina, Marie Donzel, et al.
Haematologica|May 31, 2022
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baselineCédric Rossi, Marc André, Jehan Dupuis, et al.
The American Journal of Surgical Pathology|December 13, 2018
Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSAClémentine Sarkozy, Christiane Copie-Bergman, Diane Damotte, et al.
Pageof 15